Company: BGLC
Filing Date: 2025-11-07
Form Type: S-3
Source: 0001477932-25-007976
Chunk: 15

Company: BioNexus Gene Lab Corp
Filing Date: 2025-11-07
Form: S-3
Chunk 15
---
,540 restricted stocks outstanding.

Other Convertible Securities

As of the date of this prospectus, we do not have any outstanding convertible securities.

Securities Authorized for Issuance under Equity Compensation Plans

We have not adopted any compensatory or benefit plans for future issuances of our securities but reserve the right to do so in the future.

Transfer Agent

The stock transfer agent for our securities is Securities Transfer Corporation, 2901 N. Dallas Parkway, Suite 380, Plano, TX 75093, USA.

Anti-Takeover Effects of Our Charter Documents and Wyoming Law

The following is a brief description of the provisions in our Articles of Incorporation and Bylaws that could have an effect of delaying, deferring, or preventing a change in control of the Company.

| 8 |

Authorized Shares

Our Articles of Incorporation, as amended, authorize 300,000,000 shares of common stock, no par value, and 30,000,000 shares of preferred stock, no par value. Our board of directors may issue shares of preferred stock in one or more series and fix the rights and preferences of any such series without shareholder approval. The availability of authorized but unissued common and “blank-check” preferred stock could, among other things, render more difficult or discourage an attempt to obtain control of the Company through a proxy contest, tender offer, merger or otherwise.

No Cumulative Voting

Neither our Articles of Incorporation nor our Bylaws provide for cumulative voting in the election of directors. Accordingly, holders of a majority of the shares entitled to vote in any election of directors can elect all of the directors standing for election. (See our Bylaws and Articles of Incorporation.)

Number of Directors; Vacancies; Removal

Our Bylaws provide that the number of directors may be increased or decreased by the board of directors. Any vacancy on the board may be filled by a majority of the remaining directors, with the appointee serving until the next election of directors. Our Bylaws also provide that any director or the entire board may be removed, with or without cause, by the vote or written consent of stockholders representing not less than a majority of the outstanding voting power. These provisions could make it more difficult for shareholders to remove incumbent directors or to effect a change in control of the board.

Control Share Acquisitions (Wyoming Management Stability Act, Article 3)

Wyoming’s “control share” provisions may apply to acquisitions of a “controlling interest” in a Wyoming corporation (generally crossing specified voting power